![1P-0136 Effect of pioglitazone on atherogenic outcomes in patients with type 2 diabetes: Comparison with responder and non-responder groups]()
1P-0136 Effect of pioglitazone on atherogenic outcomes in patients with type 2 diabetes: Comparison with responder and non-responder groupsJimbu, Y.; Igarashi, M.; Kimura, M.; Hirata, A.; Yamaguchi, H.; Kato, T.; Tominaga, M. · Atherosclerosis Supplements · 2003